GlassScriptPhysician profile
Nazeer U Shaik
NPI 1295813996
$1,914.26
in general payments reported to CMS, 2019-2025
18 companies · $54.03 in 2025
The $54.03 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.34 · 2020: $565 · 2021: $789 · 2022: $215 · 2023: $207 · 2024: $59.63 · 2025: $54.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $320.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $322.75 | 2019-2021 | |
| Pfizer INC. | $291.61 | 2020-2021 | |
| Vanda Pharmaceuticals INC. | $281.86 | 2020-2021 | |
| Glaxosmithkline, LLC. | $202.33 | 2020-2025 | Trelegy Ellipta |
| Lilly USA, LLC | $192.77 | 2020-2025 | Mounjaro |
| E.R. Squibb & Sons, L.L.C. | $148.13 | 2020-2023 | Eliquis |
| Astrazeneca Pharmaceuticals LP | $107.54 | 2021-2023 | Evusheld, Farxiga |
| Abbott Laboratories | $77.18 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $69.78 | 2019-2023 | Xifaxan |
| Preventric Diagnostics, INC. | $55.42 | 2021 | |
| Novartis Pharmaceuticals Corporation | $50.29 | 2021-2023 | |
| Sunovion Pharmaceuticals INC. | $21.16 | 2020 | |
| Xeris Pharmaceuticals, INC. | $18.46 | 2022 | |
| Amarin Pharma, INC. | $17.43 | 2022 | |
| Genentech USA, INC. | $16.53 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $13.90 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.58 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nazeer Shaik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.